Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

This page is alzhub.org's plain-English summary of a published study, not the paper itself. It is generated from the record we hold for this study, sourced and linked below — check the original for the full text and methods.

✓ Peer-reviewed alzhub usefulness score 38 out of 100. Health systems and care delivery

Topic: Risk, prevention and care in population studies

Among the 1,035 patients in our dataset, 176 (17%) had a dementia diagnosis. Mean monthly home care costs for dementia patients were CHF 362 (Swiss francs) higher (mean: CHF 1,082; median: CHF 812) than for non-dementia patients (mean: CHF 720; median: CHF: 457). ADL and IADL were the most important predictors of home care costs. Introducing dementia diagnosis or cognitive impairment or both alongside ADL, IADL, living alone, age and gender did not materially change prediction performance (AIC remains unchanged, BIC changes + 1.09 to + 6.36 in the main model). Our findings give no support for the implementation of differentiated reimbursement tariffs or risk adjustment models for dementia patients or patients with cognitive impairment. More general predictors, such as ADL and IADL impairments seem to predict home nursing care costs adequately enough. However, further research with larger and more representative samples in other countries is necessary to validate these findings. CLINICAL TRIAL NUMBER: Not applicable.

Key findings

Why it matters

This study examined whether including dementia diagnosis or cognitive impairment improves prediction of home care costs. It found these factors did not materially improve prediction beyond daily living measures, which concerns cost prediction rather than treating, curing or preventing Alzheimer's disease.

Study details

How this study scored 38/100
How this study's score is builtJournal tier 7 of 10; Journal's citation record 2 of 4; Study design 0 of 12; Strength of evidence 1 of 5; Peer-review validation 10 of 10; How recent 4 of 5; Sample size 3 of 4; Effect reported 0 of 3; Studied in people 3 of 3; Randomised / blinded 0 of 2; Times cited 0 of 7; Citations per year 0 of 5; Impact for its field and year 0 of 6; Cited by studies here 0 of 6; Still being cited 0 of 4; Senior author's track record left out, no data; Institution's track record 1 of 3; Multi-centre collaboration 1 of 3; Indexed in PubMed 2 of 2; Free to read 2 of 2. 36 of the 96 points it could be judged on, which is 38 of 100. Total 38 of 100.36 of the 96 points we could judge = 38 of 100

Published in a peer-reviewed journal. Scored zero for study design, effect reported and randomised / blinded because the record does not state it. We have no data on senior author's track record, so that was left out: it earned 36 of the 96 points we could judge it on, which is 38 out of 100.

ComponentPointsWhy
Journal tier 7 / 10 Tier 3 — peer-reviewed journal (BMC Health Services Research)
Journal's citation record 2 / 4 BMC Health Services Research: journal h-index 218 (OpenAlex, 2026-10-29)
Study design 0 / 12 No study design recorded — scores zero, not guessed (not stated in the record — scored 0)
Strength of evidence 1 / 5 Rated “low” in our summary
Peer-review validation 10 / 10 Peer-reviewed. Published as an article in a named peer-reviewed journal.
How recent 4 / 5 2025 — within 3 year(s) of the newest study here
Sample size 3 / 4 1,035 participants
Effect reported 0 / 3 No effect size reported — scores zero (not stated in the record — scored 0)
Studied in people 3 / 3 Studied in people (participant count stated)
Randomised / blinded 0 / 2 No randomisation or blinding stated — scores zero (not stated in the record — scored 0)
Times cited 0 / 7 Cited 0 times (OpenAlex, 2026-10-10)
Citations per year 0 / 5 0.0 citations a year over 3 year(s) since 2025
Impact for its field and year 0 / 6 Cited 0.0× the average for papers of its field and year (OpenAlex FWCI)
Cited by studies here 0 / 6 No other study in this library cites it
Still being cited 0 / 4 Cited 0 times in 2024–2026 (2026 still in progress; OpenAlex)
Senior author's track record — / 4 OpenAlex's profile for last-listed author Simon Wieser holds only 7 work(s), too few to judge a track record — left out of this score
Institution's track record 1 / 3 University of Basel: institution h-index 928 (OpenAlex)
Multi-centre collaboration 1 / 3 OpenAlex lists 3 institution(s) in 1 country
Indexed in PubMed 2 / 2 Indexed in PubMed (PMID 41430206)
Free to read 2 / 2 Free to read
Points 36 / 96 Scored on 19 of 20 parts. We have no data for the rest, so they are left out: 36 of the 96 points we could judge it on is 38 out of 100.
Total 38 / 100 —

What each of these 20 components measures, and what this score is not →

Read the original

Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).

Cite this study APA, Vancouver, BibTeX · download .bib or .ris

Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.

APA 7th

Meier-Schwarzer, F., Probst-Hensch, N. M., Höglinger, M., Schwenkglenks, M., & Wieser, S. (2025). Should we include dementia diagnosis or cognitive impairment to predict home care cost? An observational study using real-world data. BMC Health Services Research. https://doi.org/10.1186/s12913-025-13868-2

Vancouver

Meier-Schwarzer F, Probst-Hensch NM, Höglinger M, Schwenkglenks M, Wieser S. Should we include dementia diagnosis or cognitive impairment to predict home care cost? An observational study using real-world data. BMC Health Services Research. 2025. doi:10.1186/s12913-025-13868-2. PMID: 41430206.

BibTeX

@article{meierschwarzer2025-41430206,
  author  = {Meier-Schwarzer, Flurina and Probst-Hensch, Nicole M and Höglinger, Marc and Schwenkglenks, Matthias and Wieser, Simon},
  title   = {{Should we include dementia diagnosis or cognitive impairment to predict home care cost? An observational study using real-world data}},
  journal = {BMC Health Services Research},
  year    = {2025},
  doi     = {10.1186/s12913-025-13868-2},
  pmid    = {41430206},
  url     = {https://doi.org/10.1186/s12913-025-13868-2}
}

Studies this one cites

Referenced by this study and also in the alzhub library, so you can read them here.

Related studies in Health systems and care delivery

Also tagged “prevalence”

1,224 studies in the library carry the topic tag “prevalence”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 1,224 tagged studies.

Similar studies

More on Health systems and care delivery

See all studies in Health systems and care delivery →